- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
-
Seok J, Suk KT, Kim DJ
- KMID: 2409648
- J Liver Cancer.
- 2018 Mar;18(1):51-54.
- doi: 10.17998/jlc.18.1.51
Non-alcoholic fatty liver disease (NAFLD) has been one of the causes of cryptogenic hepatocellular carcinoma (HCC). NAFLD-associated HCC (NAFLD-HCC) have clinical features such as high body mass index, deranged lipid... -
- CITED
-
- Close
- SHARE
-
- Close
- Systemic Therapy for Advanced Hepatocellular Carcinoma: Targeted Therapy and Immunotherapy
-
Kim BH, Park JW
- KMID: 2409644
- J Liver Cancer.
- 2018 Mar;18(1):17-22.
- doi: 10.17998/jlc.18.1.17
Systemic therapy for hepatocellular carcinoma (HCC) has markedly changed since 2007, with the approval of sorafenib. Sorafenib improved the overall survival of patients with advanced HCC; however, the modest efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Translational Application of Single-cell Transcriptomic Analysis in Hepatocellular Carcinoma
-
Yoon SK
- KMID: 2409642
- J Liver Cancer.
- 2018 Mar;18(1):1-8.
- doi: 10.17998/jlc.18.1.1
The emergence of single-cell technology in recent years has made remarkable progress for understanding of biological process in various diseases including cancers. In particular of cancer, single-cell transcriptome analysis provides... -
- CITED
-
- Close
- SHARE
-
- Close
- Needle-tract Seeding of Hepatocellular Carcinoma at Chest Wall: A Report of Two Cases
-
Kim DJ, Kim G
- KMID: 2409650
- J Liver Cancer.
- 2018 Mar;18(1):63-66.
- doi: 10.17998/jlc.18.1.63
We report two cases of needle-tract seeding after cryoablation and radiofrequency ablation for hepatocellular carcinomas. The seeding nodule appeared 6 and 12 months on the follow-up computed tomographic scan, respectively.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Hepatocellular Carcinoma Treated by Proton Beam Therapy as 1st Choice
-
Oh J, Sinn DH, Seong G, Chung HG, Heo C, Yu J, Park HC
- KMID: 2409653
- J Liver Cancer.
- 2018 Mar;18(1):80-85.
- doi: 10.17998/jlc.18.1.80
Although first-line treatment option for single, small sized hepatocellular carcinoma in patients with preserved liver function and good performance status is resection or ablation, sometimes these modalities cannot be applied... -
- CITED
-
- Close
- SHARE
-
- Close
- Noninvasive Diagnostic Criteria of the Revised 2014 the Korean Liver Cancer Study Group and the National Cancer Center Guideline for Subcentimetersized Hepatocellular Carcinoma: Is It Too Strict?
-
Kim NJ, Sinn DH, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Gwak GY
- KMID: 2409647
- J Liver Cancer.
- 2018 Mar;18(1):44-50.
- doi: 10.17998/jlc.18.1.44
BACKGROUND/AIMS: Noninvasive diagnostic criteria for hepatocellular carcinoma (HCC) differ between guidelines, especially for subcentimeter-sized nodules. This study aimed to analyze clinical and radiological characteristics of subcentimeter-sized HCC, and assess the... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Response Evaluation after Treatment and Post-treatment Surveillance of Hepatocellular Carcinoma
-
Yoon JS, Park SY
- KMID: 2409643
- J Liver Cancer.
- 2018 Mar;18(1):9-16.
- doi: 10.17998/jlc.18.1.9
Hepatocellular carcinoma is one of the most prevalent malignancies and frequent causes of death worldwide. Treatment options of hepatocellular carcinoma consist of locoregional therapy, surgical resection, liver transplantation, and systemic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Management for Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis by Autologous Natural Killer Cells Combined with Immune Checkpoint Inhibitor
-
Woo A, Kim EJ, Shin SY, Jeon HJ, Park H, Chon YE, Lee YB, Hwang SG, Rim KS, Lee JH
- KMID: 2409651
- J Liver Cancer.
- 2018 Mar;18(1):67-74.
- doi: 10.17998/jlc.18.1.67
Hepatocellular carcinoma (HCC) has extremely poor prognosis. Immunotherapy has emerged as a new treatment for a number of cancers. Adoptive immunotherapy is one of the important cancer immunotherapy, which relies... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Complete Response with Biliary Stenosis after Hepatic Arterial Injection and Stereotactic Body Radiotherapy to Hepatoecllular Carcinoma with Portal Vein Thrombosis
-
Rim CH, Im HJ, Jung YG, Chung HH, Seo SJ, Yoon WS
- KMID: 2409652
- J Liver Cancer.
- 2018 Mar;18(1):75-79.
- doi: 10.17998/jlc.18.1.75
Curative treatment of hepatocellular carcinoma (HCC) with portal vein invasion is difficult to achieve, and the prognosis is dismal. Combining external beam radiotherapy (EBRT) with hepatic arterial infusion chemotherapy (HAIC)... -
- CITED
-
- Close
- SHARE
-
- Close
- The Feasibility Study of Contrast-enhanced Ultrasound Using a 3 Dimension Transducer for Tumor Volume Measurement in Rabbit Hepatic VX2 Carcinoma Comparison with 2 Dimension Ultrasound and 3 Dimension Ultrasound without Contrast: Preliminary Results
-
Kim J, Kim JH, Choi SY, Han JK
- KMID: 2409645
- J Liver Cancer.
- 2018 Mar;18(1):23-32.
- doi: 10.17998/jlc.18.1.23
BACKGROUND/AIMS: To investigate the feasibility of tumor volume measurement using contrastenhanced ultrasound (US) with 3 dimension transducer (3D CEUS) in rabbit hepatic VX2 carcinoma. METHODS: Three different tumor volume measurements, including... -
- CITED
-
- Close
- SHARE
-
- Close
- Spontaneous Regression of Massive Infiltrative Hepatocellular Carcinoma with Change in Hepatic Contour: A Case Report with Literature Review
-
Lee EH, Oh MJ
- KMID: 2409649
- J Liver Cancer.
- 2018 Mar;18(1):55-62.
- doi: 10.17998/jlc.18.1.55
Spontaneous regression of hepatocellular carcinoma (HCC) is associated with alcohol abstinence, herbal medication, radiation, ischemia and immune reaction against systemic or local infections. Herein, we report a case of 67-year-old... -
- CITED
-
- Close
- SHARE
-
- Close
- Methionine Adenosyltransferase 1: A Proteomic Surrogate Marker of Early Hepatocellular Carcinoma in Cirrhotic Patients
-
Lee JH, Jun MJ, Shim JH, Song GW, Tak E, Oh B, Yu E, Choi SW, An J, Lee D, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS
- KMID: 2409646
- J Liver Cancer.
- 2018 Mar;18(1):33-43.
- doi: 10.17998/jlc.18.1.33
BACKGROUND/AIMS: Because there is a lack of effective biomarkers, we aimed to discover proteomic candidate markers for hepatocellular carcinoma (HCC) in cirrhotic patients at the highest-risk of HCC, and to... -
- CITED
-
- Close
- SHARE
-
- Close
